Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CBER Director Marks: Regenerative Medicine Enforcement Will Be 'Notched Up' In 2018

Jan 18 2018

• By Michael Cipriano

Related Content

Regenerative Medicines Provisions Of Cures Act A Top Priority For CBER

Jun 09 2017

Regenerative Medicine Clinical Trials: US FDA Supports Studies Comparing Multiple Agents

Nov 17 2017

US FDA's Drug Seizures Seen As Most Significant Aspect Of Stem Cell Crackdown

Sep 06 2017

Crackdown On Bad Regenerative Medicine Could Benefit Gene Therapy

Aug 28 2017

Additional Topics

United States Regenerative Medicine Safety Regulation BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window